scalable-transfection-of-maize-mesophyll-protoplasts

Scalable Transfection of Maize Mesophyll Protoplasts

The transfection of maize mesophyll cells often involves digesting the plant cell walls to create protoplasts and then inserting DNA via electroporation ...

University of Washington

Long-term genetic studies utilizing backcross and congenic strain analyses coupled with positional cloning strategies and functional studies identified , , and  as mouse plasmacytoma susceptibility/resistance genes. Tumor incidence data in congenic strains carrying the resistance alleles of  and  led us to hypothesize that drug combinations affecting these pathways are likely to have an additive, if not synergistic effect in inhibiting tumor cell growth. Traditional and novel systems-level genomic approaches were used to assess combination activity, disease specificity, and clinical potential of a drug combination involving rapamycin/everolimus, an  inhibitor, with entinostat, an histone deacetylase inhibitor. The combination synergistically repressed oncogenic  and activated the  tumor suppressor. The identification of  as a primary upstream regulator led to the identification of small molecule binders of the G-quadruplex structure that forms in the NHEIII region of the  promoter. These studies highlight the importance of identifying drug combinations which simultaneously upregulate tumor suppressors and downregulate oncogenes.

Sayeh Gorjifard

Genome Sciences Department

University of Washington

Scalable Transfection of Maize Mesophyll Protoplasts

Sayeh Gorjifard

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Genome Sciences Department

University of Washington

Scalable Transfection of Maize Mesophyll Protoplasts

Genome Sciences Department